Feb 25, 2024, 15:31
Aaron Goodman: Until a trial demonstrates melflufen is superior to melphalan I see no reason to use it
Aaron Goodman shared a post on X:
“Chemo is bad and toxic!
Attach a peptide and charge a lot of money for it and it’s all the rage.
Until a trial demonstrates melflufen is superior to melphalan I see no reason to use it.”
View additional information.
Source: Aaron Goodman/X
Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 9, 2024, 20:13
Dec 9, 2024, 20:11
Dec 9, 2024, 20:06
Dec 9, 2024, 19:30
Dec 9, 2024, 19:25